ImmuDyne Inc. Announces First Quarter Results.Business Editors & Health/Medical Writers HOUSTON--(BUSINESS WIRE)--Jan. 10, 2003 ImmuDyne Inc. (ImmuDyne or the Company), a Texas-based nutraceuticals company specializing in scientifically based dietary supplements Noun 1. dietary supplement - something added to complete a diet or to make up for a dietary deficiency diet - a prescribed selection of foods vitamin pill - a pill containing one or more vitamins; taken as a dietary supplement , skin care cosmetics and animal nutrition, announced unaudited results for the first quarter ending Nov. 30, 2002. For the quarter ending Nov. 30, 2002, revenues were $332,904 as compared to $332,386 for the quarter ending Nov. 30, 2001. Operating expenses Operating expenses The amount paid for asset maintenance or the cost of doing business, excluding depreciation. Earnings are distributed after operating expenses are deducted. were $234,973 as compared to $287,613 a year ago, a decrease of 18%. Net loss was ($53,215) as compared to ($78,057) for the same quarter a year ago, a decrease of 30%. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. The statements which are not facts contained in the release are forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. that involve risks and uncertainties, some of which are outside the Company's control, and accordingly, actual results may differ materially. Factors that might cause such a difference include, but are not limited to, implementation of the Company's strategies, the impact of competitive and industry developments, the results of research and development efforts by the Company, product development by the Company and customer acceptance of the Company's products and services. ImmuDyne is a Texas-based nutraceuticals company, specializing in scientifically based dietary supplements, skin care cosmetics and animal nutrition. The common stock of ImmuDyne is traded on the Pink Sheets under the symbol IMMD IMMD Immediate IMMD Institut für Mathematische Maschinen und Datenverarbeitung . |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion